4//SEC Filing
Vida Ventures, LLC 4
Accession 0000899243-18-009441
CIK 0001661998other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:24 PM ET
Size
11.0 KB
Accession
0000899243-18-009441
Insider Transaction Report
Form 4
Vida Ventures, LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-04-02+395,845→ 395,845 total(indirect: See footnote) - Purchase
Common Stock
2018-04-02$16.00/sh+375,000$6,000,000→ 770,845 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2018-04-02−395,845→ 0 total(indirect: See footnote)→ Common Stock (395,845 underlying)
VV Manager LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-04-02$16.00/sh+375,000$6,000,000→ 770,845 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2018-04-02−395,845→ 0 total(indirect: See footnote)→ Common Stock (395,845 underlying) - Conversion
Common Stock
2018-04-02+395,845→ 395,845 total(indirect: See footnote)
Footnotes (2)
- [F1]The securities reported herein are held of record by Vida Ventures, LLC ("Vida"). VV Manager, LLC is the mananging member of Vida. As a result, VV Manager, LLC may be deemed to beneficially own the securities held by Vida. VV Manager, LLC is managed by five directors, each of who disclaim beneficial ownership over the securities held of record by Vida except to the extent of their pecuniary interest therein.
- [F2]Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001724489
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:24 PM ET
- Size
- 11.0 KB